Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents

Numerous angiogenesis-vascular targeting agents have been admitted to the ranks of cancer therapeutics; most of them are used in polytherapy regimens. This review will address recent progress together with our preclinical experience in combining angiogenesis inhibitors, mainly acting on VEGF/VEGFR p...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Marta eCesca, Francesca eBizzaro, Massimo eZucchetti, Raffaella eGiavazzi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-10-01
Subjects:	Angiogenesis Inhibitors Paclitaxel Tumor Microenvironment Drug delivery Combination therapies receptor tyrosin kinase inhibitors
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00259/full